

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to pheromone (GO:0019236) | 6.64792882 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.29978324 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.86234776 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.24054975 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 5.21877434 |
| 6 | * positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.10964830 |
| 7 | neurotransmitter secretion (GO:0007269) | 5.07851415 |
| 8 | * neuromuscular process controlling posture (GO:0050884) | 5.03783257 |
| 9 | regulation of hexokinase activity (GO:1903299) | 4.90315808 |
| 10 | regulation of glucokinase activity (GO:0033131) | 4.90315808 |
| 11 | neurotransmitter uptake (GO:0001504) | 4.83350734 |
| 12 | neurotransmitter transport (GO:0006836) | 4.68604594 |
| 13 | respiratory chain complex IV assembly (GO:0008535) | 4.66022573 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.65724754 |
| 15 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.65083951 |
| 16 | sodium ion export (GO:0071436) | 4.63957059 |
| 17 | vocalization behavior (GO:0071625) | 4.51887394 |
| 18 | glutamate secretion (GO:0014047) | 4.51830054 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.50508921 |
| 20 | protein localization to synapse (GO:0035418) | 4.38025943 |
| 21 | serotonin metabolic process (GO:0042428) | 4.32626584 |
| 22 | regulation of neurotransmitter levels (GO:0001505) | 4.24438186 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 4.19315733 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.17646493 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.16698124 |
| 26 | glycine transport (GO:0015816) | 4.14384461 |
| 27 | neurotransmitter catabolic process (GO:0042135) | 4.11879687 |
| 28 | cellular ketone body metabolic process (GO:0046950) | 4.11814153 |
| 29 | cytochrome complex assembly (GO:0017004) | 4.09412911 |
| 30 | * regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.07296011 |
| 31 | potassium ion homeostasis (GO:0055075) | 4.06356143 |
| 32 | ketone body metabolic process (GO:1902224) | 4.00645515 |
| 33 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.97739453 |
| 34 | * regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.95404063 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.93349226 |
| 36 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93198445 |
| 37 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.89627335 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.88385660 |
| 39 | locomotory exploration behavior (GO:0035641) | 3.87512756 |
| 40 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.86047491 |
| 41 | positive regulation of glycolytic process (GO:0045821) | 3.85883646 |
| 42 | DNA deamination (GO:0045006) | 3.85786329 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.82552334 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.81235747 |
| 45 | exploration behavior (GO:0035640) | 3.81181155 |
| 46 | regulation of vesicle fusion (GO:0031338) | 3.80950382 |
| 47 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.79159219 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.78981480 |
| 49 | cell communication by electrical coupling (GO:0010644) | 3.73815979 |
| 50 | glycerophospholipid catabolic process (GO:0046475) | 3.73593710 |
| 51 | signal peptide processing (GO:0006465) | 3.73336252 |
| 52 | potassium ion import (GO:0010107) | 3.71206546 |
| 53 | lactate metabolic process (GO:0006089) | 3.70940246 |
| 54 | prenylation (GO:0097354) | 3.69376046 |
| 55 | protein prenylation (GO:0018342) | 3.69376046 |
| 56 | primary amino compound metabolic process (GO:1901160) | 3.68828408 |
| 57 | response to histamine (GO:0034776) | 3.65786204 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.63401341 |
| 59 | protein complex biogenesis (GO:0070271) | 3.59519514 |
| 60 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.59185702 |
| 61 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.56933376 |
| 62 | neurofilament cytoskeleton organization (GO:0060052) | 3.56344458 |
| 63 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.54219943 |
| 64 | protein K11-linked deubiquitination (GO:0035871) | 3.52534470 |
| 65 | protein localization to cilium (GO:0061512) | 3.51813844 |
| 66 | regulation of catecholamine metabolic process (GO:0042069) | 3.51148714 |
| 67 | regulation of dopamine metabolic process (GO:0042053) | 3.51148714 |
| 68 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45941620 |
| 69 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.42707063 |
| 70 | * regulation of respiratory system process (GO:0044065) | 3.41937048 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.41862549 |
| 72 | neuron recognition (GO:0008038) | 3.40740006 |
| 73 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.37657057 |
| 74 | synaptic transmission, glutamatergic (GO:0035249) | 3.34896473 |
| 75 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.34552201 |
| 76 | long-term memory (GO:0007616) | 3.32934171 |
| 77 | glutamate receptor signaling pathway (GO:0007215) | 3.32858125 |
| 78 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.31721096 |
| 79 | * membrane hyperpolarization (GO:0060081) | 3.31517809 |
| 80 | cellular sodium ion homeostasis (GO:0006883) | 3.31512168 |
| 81 | endocrine pancreas development (GO:0031018) | 3.31225584 |
| 82 | L-amino acid import (GO:0043092) | 3.30959400 |
| 83 | * neuron-neuron synaptic transmission (GO:0007270) | 3.30936312 |
| 84 | platelet dense granule organization (GO:0060155) | 3.30545914 |
| 85 | axon cargo transport (GO:0008088) | 3.29429986 |
| 86 | proline transport (GO:0015824) | 3.27347126 |
| 87 | activation of protein kinase A activity (GO:0034199) | 3.26976515 |
| 88 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.23567640 |
| 89 | layer formation in cerebral cortex (GO:0021819) | 3.23378806 |
| 90 | nitric oxide mediated signal transduction (GO:0007263) | 3.19727403 |
| 91 | insulin secretion (GO:0030073) | 3.19611802 |
| 92 | inositol phosphate catabolic process (GO:0071545) | 3.19273177 |
| 93 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.18671376 |
| 94 | neuromuscular synaptic transmission (GO:0007274) | 3.17857962 |
| 95 | polyol catabolic process (GO:0046174) | 3.16927019 |
| 96 | behavioral response to nicotine (GO:0035095) | 3.15065169 |
| 97 | dopamine transport (GO:0015872) | 3.14960340 |
| 98 | L-fucose catabolic process (GO:0042355) | 3.11690519 |
| 99 | fucose catabolic process (GO:0019317) | 3.11690519 |
| 100 | L-fucose metabolic process (GO:0042354) | 3.11690519 |
| 101 | nonmotile primary cilium assembly (GO:0035058) | 3.11637345 |
| 102 | cAMP-mediated signaling (GO:0019933) | 3.11491713 |
| 103 | establishment of synaptic vesicle localization (GO:0097480) | 3.10323433 |
| 104 | synaptic vesicle transport (GO:0048489) | 3.10323433 |
| 105 | behavioral defense response (GO:0002209) | 3.08694020 |
| 106 | behavioral fear response (GO:0001662) | 3.08694020 |
| 107 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07576120 |
| 108 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.05772278 |
| 109 | keratinocyte development (GO:0003334) | 3.05555688 |
| 110 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.04595784 |
| 111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.04595784 |
| 112 | NADH dehydrogenase complex assembly (GO:0010257) | 3.04595784 |
| 113 | regulation of neurotransmitter secretion (GO:0046928) | 3.02662095 |
| 114 | mating behavior (GO:0007617) | 3.02639399 |
| 115 | negative regulation of acute inflammatory response (GO:0002674) | 3.02270532 |
| 116 | * adult walking behavior (GO:0007628) | 3.01999208 |
| 117 | central nervous system myelination (GO:0022010) | 3.00546051 |
| 118 | axon ensheathment in central nervous system (GO:0032291) | 3.00546051 |
| 119 | membrane depolarization during action potential (GO:0086010) | 2.99912962 |
| 120 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.98712396 |
| 121 | * startle response (GO:0001964) | 2.97687624 |
| 122 | cell differentiation in hindbrain (GO:0021533) | 2.97219888 |
| 123 | presynaptic membrane assembly (GO:0097105) | 2.96633698 |
| 124 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.95475398 |
| 125 | axoneme assembly (GO:0035082) | 2.95471334 |
| 126 | positive regulation of respiratory burst (GO:0060267) | 2.94409466 |
| 127 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93623571 |
| 128 | dendritic spine morphogenesis (GO:0060997) | 2.93024029 |
| 129 | * regulation of respiratory gaseous exchange (GO:0043576) | 2.92929603 |
| 130 | response to auditory stimulus (GO:0010996) | 2.92720557 |
| 131 | regulation of cilium movement (GO:0003352) | 2.92081002 |
| 132 | postsynaptic membrane organization (GO:0001941) | 2.91222681 |
| 133 | positive regulation of insulin secretion (GO:0032024) | 2.90924451 |
| 134 | positive regulation of peptide hormone secretion (GO:0090277) | 2.89961917 |
| 135 | presynaptic membrane organization (GO:0097090) | 2.89730679 |
| 136 | * regulation of postsynaptic membrane potential (GO:0060078) | 2.89479224 |
| 137 | mannosylation (GO:0097502) | 2.89261529 |
| 138 | kidney morphogenesis (GO:0060993) | 2.88987730 |
| 139 | regulation of neurotransmitter transport (GO:0051588) | 2.88779934 |
| 140 | signal release (GO:0023061) | 2.88459590 |
| 141 | negative regulation of protein oligomerization (GO:0032460) | 2.87920701 |
| 142 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.87332354 |
| 143 | * synaptic transmission (GO:0007268) | 2.85123107 |
| 144 | protein K6-linked ubiquitination (GO:0085020) | 2.84408918 |
| 145 | synapse assembly (GO:0007416) | 2.82552126 |
| 146 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.82517457 |
| 147 | membrane repolarization (GO:0086009) | 2.82434157 |
| 148 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.76254925 |
| 149 | inositol phosphate dephosphorylation (GO:0046855) | 2.76254925 |
| 150 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.76044029 |
| 151 | positive regulation of peptide secretion (GO:0002793) | 2.75264126 |
| 152 | protein polyglutamylation (GO:0018095) | 2.73012003 |
| 153 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.70870019 |
| 154 | positive regulation of protein autophosphorylation (GO:0031954) | 2.69215439 |
| 155 | photoreceptor cell maintenance (GO:0045494) | 2.68887053 |
| 156 | indolalkylamine metabolic process (GO:0006586) | 2.66861331 |
| 157 | detection of light stimulus involved in visual perception (GO:0050908) | 2.65369602 |
| 158 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.65369602 |
| 159 | cilium morphogenesis (GO:0060271) | 2.62779983 |
| 160 | amine catabolic process (GO:0009310) | 2.56309295 |
| 161 | cellular biogenic amine catabolic process (GO:0042402) | 2.56309295 |
| 162 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.55231246 |
| 163 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.55231246 |
| 164 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.53705965 |
| 165 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.53705965 |
| 166 | retinal cone cell development (GO:0046549) | 2.52606701 |
| 167 | regulation of neurotransmitter uptake (GO:0051580) | 2.51157337 |
| 168 | negative regulation of telomere maintenance (GO:0032205) | 2.50989127 |
| 169 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.50758262 |
| 170 | establishment of protein localization to Golgi (GO:0072600) | 2.48473119 |
| 171 | alanine transport (GO:0032328) | 2.48415740 |
| 172 | adaptation of signaling pathway (GO:0023058) | 2.45838367 |
| 173 | indole-containing compound catabolic process (GO:0042436) | 2.44348360 |
| 174 | indolalkylamine catabolic process (GO:0046218) | 2.44348360 |
| 175 | tryptophan catabolic process (GO:0006569) | 2.44348360 |
| 176 | auditory receptor cell stereocilium organization (GO:0060088) | 2.43136583 |
| 177 | anterograde synaptic vesicle transport (GO:0048490) | 2.41120427 |
| 178 | protein-cofactor linkage (GO:0018065) | 2.41027669 |
| 179 | negative regulation of gluconeogenesis (GO:0045721) | 2.38452868 |
| 180 | cilium organization (GO:0044782) | 2.37226315 |
| 181 | branched-chain amino acid catabolic process (GO:0009083) | 2.36825864 |
| 182 | protein localization to Golgi apparatus (GO:0034067) | 2.36632489 |
| 183 | C-terminal protein amino acid modification (GO:0018410) | 2.35839410 |
| 184 | C-terminal protein lipidation (GO:0006501) | 2.35810102 |
| 185 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.35505024 |
| 186 | S-adenosylmethionine metabolic process (GO:0046500) | 2.35334729 |
| 187 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.35208917 |
| 188 | piRNA metabolic process (GO:0034587) | 2.34203210 |
| 189 | fatty acid homeostasis (GO:0055089) | 2.34195516 |
| 190 | epithelial cilium movement (GO:0003351) | 2.34147954 |
| 191 | cilium assembly (GO:0042384) | 2.33299848 |
| 192 | regulation of insulin secretion (GO:0050796) | 2.32758990 |
| 193 | phasic smooth muscle contraction (GO:0014821) | 2.32383301 |
| 194 | serotonin receptor signaling pathway (GO:0007210) | 2.31855577 |
| 195 | kynurenine metabolic process (GO:0070189) | 2.30306050 |
| 196 | GPI anchor metabolic process (GO:0006505) | 2.29970420 |
| 197 | photoreceptor cell development (GO:0042461) | 2.29771121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.36696457 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06854163 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.22113645 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.11292717 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.01608472 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.98834846 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.85531944 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68183208 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68183208 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64502361 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54397408 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.52916872 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50710047 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47281666 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46981506 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41438279 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38953335 |
| 18 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37642230 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33347390 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.31119904 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28594040 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26220870 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 2.19009786 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17873072 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.16399372 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14141276 |
| 27 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12169378 |
| 28 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10327427 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.10187142 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08137685 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04988368 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98621373 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98381763 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.93626834 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.90294492 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89968692 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88992343 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85538308 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82600991 |
| 40 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78293124 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74664270 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72536429 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72295985 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68520992 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66665671 |
| 46 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.66561181 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59720483 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.58339281 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56854574 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.56743473 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.55825301 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.55694359 |
| 53 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.54792580 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54371941 |
| 55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.53437868 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.52637368 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52592551 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52592551 |
| 59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.51427576 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.51149299 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.46001718 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44717150 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43263911 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42845685 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.42363685 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39873330 |
| 67 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38553337 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.37494533 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37237870 |
| 70 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37236819 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36540286 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.35752641 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.34473239 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33783181 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.33645824 |
| 76 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32771626 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30378119 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29706769 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29643788 |
| 80 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29376965 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28666569 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27811966 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27288957 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27288957 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27114557 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25583264 |
| 87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.25225476 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.24979598 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24887478 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23266488 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.23232270 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22405079 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.21825065 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21037005 |
| 95 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20223757 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19182035 |
| 97 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19075116 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18988192 |
| 99 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18957820 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18930050 |
| 101 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18930050 |
| 102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18275314 |
| 103 | NCOR_22424771_ChIP-Seq_293T_Human | 1.17277466 |
| 104 | AR_19668381_ChIP-Seq_PC3_Human | 1.17135814 |
| 105 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16819632 |
| 106 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15641860 |
| 107 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15526352 |
| 108 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15174047 |
| 109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15158277 |
| 110 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13774790 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12625764 |
| 112 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11336285 |
| 113 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11300575 |
| 114 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11183752 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10079157 |
| 116 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09110136 |
| 117 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09050636 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08043050 |
| 119 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07696329 |
| 120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07091880 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06544541 |
| 122 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06114315 |
| 123 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.05999315 |
| 124 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05363698 |
| 125 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04565878 |
| 126 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03903404 |
| 127 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03778070 |
| 128 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03714252 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03297514 |
| 130 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03115233 |
| 131 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.02835028 |
| 132 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02443838 |
| 133 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.02049926 |
| 134 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00687577 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99724791 |
| 136 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98374249 |
| 137 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97356747 |
| 138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97344956 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96814259 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96573874 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96166599 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95794412 |
| 143 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95144792 |
| 144 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93524382 |
| 145 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92510775 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91330050 |
| 147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91310777 |
| 148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89142404 |
| 149 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89101997 |
| 150 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86236000 |
| 151 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86032506 |
| 152 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84495675 |
| 153 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84179896 |
| 154 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.83201672 |
| 155 | JUN_21703547_ChIP-Seq_K562_Human | 0.82865271 |
| 156 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81745987 |
| 157 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81731295 |
| 158 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81425539 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81143186 |
| 160 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80560695 |
| 161 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79757692 |
| 162 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.79572877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.10857723 |
| 2 | MP0002102_abnormal_ear_morphology | 4.34752472 |
| 3 | MP0005423_abnormal_somatic_nervous | 4.19678415 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 4.04777424 |
| 5 | MP0003195_calcinosis | 4.04481451 |
| 6 | MP0006276_abnormal_autonomic_nervous | 3.68555693 |
| 7 | * MP0003635_abnormal_synaptic_transmissio | 3.52059269 |
| 8 | MP0001501_abnormal_sleep_pattern | 3.49618230 |
| 9 | MP0003122_maternal_imprinting | 3.20120951 |
| 10 | * MP0009046_muscle_twitch | 3.11344159 |
| 11 | * MP0002064_seizures | 3.11222739 |
| 12 | MP0009745_abnormal_behavioral_response | 2.98619031 |
| 13 | MP0004270_analgesia | 2.86214952 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.80586780 |
| 15 | * MP0002272_abnormal_nervous_system | 2.78371323 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.60970573 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.59823085 |
| 18 | MP0002163_abnormal_gland_morphology | 2.53651310 |
| 19 | * MP0001486_abnormal_startle_reflex | 2.49788033 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.48430580 |
| 21 | * MP0004142_abnormal_muscle_tone | 2.36269405 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.34775261 |
| 23 | MP0005379_endocrine/exocrine_gland_phen | 2.30071833 |
| 24 | MP0001529_abnormal_vocalization | 2.26447122 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.24962823 |
| 26 | MP0000372_irregular_coat_pigmentation | 2.24823623 |
| 27 | * MP0002067_abnormal_sensory_capabilities | 2.03342296 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.99904927 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.99409779 |
| 30 | * MP0005551_abnormal_eye_electrophysiolog | 1.98556551 |
| 31 | MP0004885_abnormal_endolymph | 1.90359799 |
| 32 | MP0003123_paternal_imprinting | 1.88043503 |
| 33 | MP0001986_abnormal_taste_sensitivity | 1.84907752 |
| 34 | MP0002184_abnormal_innervation | 1.84628462 |
| 35 | MP0002693_abnormal_pancreas_physiology | 1.84052506 |
| 36 | MP0002736_abnormal_nociception_after | 1.83316401 |
| 37 | MP0001970_abnormal_pain_threshold | 1.82940397 |
| 38 | MP0004043_abnormal_pH_regulation | 1.81790834 |
| 39 | * MP0004924_abnormal_behavior | 1.79780599 |
| 40 | * MP0005386_behavior/neurological_phenoty | 1.79780599 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.79296243 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.78426027 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74517802 |
| 44 | MP0002938_white_spotting | 1.69389254 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.67798983 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.66574692 |
| 47 | MP0010386_abnormal_urinary_bladder | 1.65934630 |
| 48 | MP0008569_lethality_at_weaning | 1.65863899 |
| 49 | MP0003787_abnormal_imprinting | 1.65396507 |
| 50 | MP0003329_amyloid_beta_deposits | 1.65276481 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.61637478 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.59332188 |
| 53 | MP0000778_abnormal_nervous_system | 1.57235274 |
| 54 | MP0000955_abnormal_spinal_cord | 1.56068917 |
| 55 | * MP0002882_abnormal_neuron_morphology | 1.52579610 |
| 56 | MP0002928_abnormal_bile_duct | 1.52240240 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.51469649 |
| 58 | MP0002254_reproductive_system_inflammat | 1.46171514 |
| 59 | MP0001905_abnormal_dopamine_level | 1.46041920 |
| 60 | MP0001944_abnormal_pancreas_morphology | 1.42130719 |
| 61 | MP0000427_abnormal_hair_cycle | 1.41777186 |
| 62 | MP0002229_neurodegeneration | 1.41710044 |
| 63 | * MP0002066_abnormal_motor_capabilities/c | 1.41577802 |
| 64 | MP0005670_abnormal_white_adipose | 1.40573879 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.40072991 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.39283035 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 1.36736747 |
| 68 | MP0001984_abnormal_olfaction | 1.31282028 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.30600726 |
| 70 | MP0003690_abnormal_glial_cell | 1.28664172 |
| 71 | MP0003121_genomic_imprinting | 1.23247511 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.21912987 |
| 73 | MP0005253_abnormal_eye_physiology | 1.21203951 |
| 74 | MP0003183_abnormal_peptide_metabolism | 1.20875430 |
| 75 | MP0001188_hyperpigmentation | 1.14425475 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 1.13552068 |
| 77 | MP0005535_abnormal_body_temperature | 1.13021894 |
| 78 | MP0003633_abnormal_nervous_system | 1.11420552 |
| 79 | MP0003879_abnormal_hair_cell | 1.09469647 |
| 80 | MP0005332_abnormal_amino_acid | 1.06108987 |
| 81 | MP0000920_abnormal_myelination | 1.05363427 |
| 82 | MP0001756_abnormal_urination | 1.04497944 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 1.04253258 |
| 84 | MP0002752_abnormal_somatic_nervous | 1.03762735 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 1.03746026 |
| 86 | MP0003634_abnormal_glial_cell | 1.03133030 |
| 87 | MP0004742_abnormal_vestibular_system | 1.02570827 |
| 88 | MP0004133_heterotaxia | 1.01729237 |
| 89 | MP0000383_abnormal_hair_follicle | 1.01703314 |
| 90 | MP0005389_reproductive_system_phenotype | 1.00593885 |
| 91 | MP0003011_delayed_dark_adaptation | 0.99933757 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.99596066 |
| 93 | MP0003136_yellow_coat_color | 0.99529326 |
| 94 | MP0000751_myopathy | 0.99460104 |
| 95 | MP0008058_abnormal_DNA_repair | 0.98720594 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.97333948 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.97039390 |
| 98 | MP0002152_abnormal_brain_morphology | 0.96972970 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.96537223 |
| 100 | MP0008057_abnormal_DNA_replication | 0.96256118 |
| 101 | MP0003283_abnormal_digestive_organ | 0.95742365 |
| 102 | MP0003631_nervous_system_phenotype | 0.95727638 |
| 103 | MP0002160_abnormal_reproductive_system | 0.95257728 |
| 104 | MP0001764_abnormal_homeostasis | 0.95100431 |
| 105 | MP0004858_abnormal_nervous_system | 0.94293722 |
| 106 | MP0004085_abnormal_heartbeat | 0.91819900 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.91133770 |
| 108 | MP0001963_abnormal_hearing_physiology | 0.89819066 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.88911176 |
| 110 | MP0003718_maternal_effect | 0.87080666 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.85388004 |
| 112 | MP0003252_abnormal_bile_duct | 0.85130628 |
| 113 | MP0003786_premature_aging | 0.85059330 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.83228952 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.83000173 |
| 116 | MP0004147_increased_porphyrin_level | 0.81578563 |
| 117 | MP0001324_abnormal_eye_pigmentation | 0.81101546 |
| 118 | MP0005448_abnormal_energy_balance | 0.79607810 |
| 119 | MP0003632_abnormal_nervous_system | 0.79143952 |
| 120 | MP0002177_abnormal_outer_ear | 0.78609247 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.78236736 |
| 122 | MP0008961_abnormal_basal_metabolism | 0.77248717 |
| 123 | MP0002638_abnormal_pupillary_reflex | 0.76454977 |
| 124 | MP0000613_abnormal_salivary_gland | 0.76123530 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.75828694 |
| 126 | MP0005310_abnormal_salivary_gland | 0.75769449 |
| 127 | MP0005408_hypopigmentation | 0.75272767 |
| 128 | MP0010329_abnormal_lipoprotein_level | 0.75232687 |
| 129 | MP0003953_abnormal_hormone_level | 0.74994123 |
| 130 | * MP0001943_abnormal_respiration | 0.73828127 |
| 131 | MP0002090_abnormal_vision | 0.73206367 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.72871079 |
| 133 | MP0004215_abnormal_myocardial_fiber | 0.72495016 |
| 134 | MP0001177_atelectasis | 0.72468260 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.72278366 |
| 136 | MP0000604_amyloidosis | 0.67413957 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.66906395 |
| 138 | MP0003137_abnormal_impulse_conducting | 0.66899779 |
| 139 | MP0002876_abnormal_thyroid_physiology | 0.60420538 |
| 140 | MP0008775_abnormal_heart_ventricle | 0.59920994 |
| 141 | * MP0002082_postnatal_lethality | 0.59557728 |
| 142 | * MP0010770_preweaning_lethality | 0.59557728 |
| 143 | MP0001299_abnormal_eye_distance/ | 0.59449291 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.58942856 |
| 145 | * MP0010769_abnormal_survival | 0.58390825 |
| 146 | MP0008874_decreased_physiological_sensi | 0.58017038 |
| 147 | MP0005195_abnormal_posterior_eye | 0.57503884 |
| 148 | MP0002822_catalepsy | 0.57123586 |
| 149 | MP0000026_abnormal_inner_ear | 0.56909306 |
| 150 | MP0000747_muscle_weakness | 0.56536641 |
| 151 | MP0008872_abnormal_physiological_respon | 0.54756309 |
| 152 | * MP0010768_mortality/aging | 0.54588502 |
| 153 | * MP0005410_abnormal_fertilization | 0.53585088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.94759868 |
| 2 | Focal seizures (HP:0007359) | 5.08032480 |
| 3 | Supranuclear gaze palsy (HP:0000605) | 5.02918772 |
| 4 | Myokymia (HP:0002411) | 4.95327992 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.71139200 |
| 6 | Visual hallucinations (HP:0002367) | 4.66241135 |
| 7 | Hypoglycemic seizures (HP:0002173) | 4.65021396 |
| 8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.38017886 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 4.33740271 |
| 10 | Absence seizures (HP:0002121) | 4.19906668 |
| 11 | Febrile seizures (HP:0002373) | 4.14370577 |
| 12 | Ketoacidosis (HP:0001993) | 4.09277279 |
| 13 | Large for gestational age (HP:0001520) | 4.06780283 |
| 14 | Hypoglycemic coma (HP:0001325) | 3.93722600 |
| 15 | Atonic seizures (HP:0010819) | 3.66745815 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.66228595 |
| 17 | Dialeptic seizures (HP:0011146) | 3.65083470 |
| 18 | Pancreatic cysts (HP:0001737) | 3.57769079 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.55681845 |
| 20 | Truncal ataxia (HP:0002078) | 3.55493094 |
| 21 | Ankle clonus (HP:0011448) | 3.54227245 |
| 22 | Pancreatic fibrosis (HP:0100732) | 3.50781868 |
| 23 | True hermaphroditism (HP:0010459) | 3.37135777 |
| 24 | Hypomagnesemia (HP:0002917) | 3.17029293 |
| 25 | Abnormal drinking behavior (HP:0030082) | 3.16984059 |
| 26 | Polydipsia (HP:0001959) | 3.16984059 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 3.16926744 |
| 28 | Molar tooth sign on MRI (HP:0002419) | 3.16926744 |
| 29 | Hyperglycemia (HP:0003074) | 3.14836386 |
| 30 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.14426165 |
| 31 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.14426165 |
| 32 | Pheochromocytoma (HP:0002666) | 3.13477980 |
| 33 | Prominent metopic ridge (HP:0005487) | 3.10775333 |
| 34 | Mutism (HP:0002300) | 3.10403018 |
| 35 | Hemiparesis (HP:0001269) | 3.09257486 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04587579 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 3.03825700 |
| 38 | Medial flaring of the eyebrow (HP:0010747) | 3.03301239 |
| 39 | Broad-based gait (HP:0002136) | 3.02070635 |
| 40 | Abnormality of binocular vision (HP:0011514) | 3.00627920 |
| 41 | Diplopia (HP:0000651) | 3.00627920 |
| 42 | Abnormality of the metopic suture (HP:0005556) | 2.98813343 |
| 43 | Symptomatic seizures (HP:0011145) | 2.98132424 |
| 44 | Hemiplegia (HP:0002301) | 2.97481787 |
| 45 | Action tremor (HP:0002345) | 2.94011535 |
| 46 | Postural instability (HP:0002172) | 2.92941383 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.92205908 |
| 48 | Nephronophthisis (HP:0000090) | 2.91235484 |
| 49 | Spastic gait (HP:0002064) | 2.89608668 |
| 50 | Dysmetria (HP:0001310) | 2.88039844 |
| 51 | Ketosis (HP:0001946) | 2.85536167 |
| 52 | Dysdiadochokinesis (HP:0002075) | 2.81722251 |
| 53 | Agitation (HP:0000713) | 2.80550109 |
| 54 | Hepatic necrosis (HP:0002605) | 2.78853946 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.78753866 |
| 56 | Depression (HP:0000716) | 2.76419172 |
| 57 | Anxiety (HP:0000739) | 2.76292605 |
| 58 | Neoplasm of the adrenal cortex (HP:0100641) | 2.75191901 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.72432967 |
| 60 | Urinary urgency (HP:0000012) | 2.70491179 |
| 61 | Genetic anticipation (HP:0003743) | 2.70398275 |
| 62 | Abnormality of the renal medulla (HP:0100957) | 2.69175955 |
| 63 | Mitochondrial inheritance (HP:0001427) | 2.68735575 |
| 64 | Hypothermia (HP:0002045) | 2.66043331 |
| 65 | Progressive macrocephaly (HP:0004481) | 2.65406649 |
| 66 | Acute necrotizing encephalopathy (HP:0006965) | 2.64298666 |
| 67 | Neuroendocrine neoplasm (HP:0100634) | 2.62312686 |
| 68 | Central scotoma (HP:0000603) | 2.62187303 |
| 69 | Increased CSF lactate (HP:0002490) | 2.60823910 |
| 70 | Drooling (HP:0002307) | 2.60500464 |
| 71 | Excessive salivation (HP:0003781) | 2.60500464 |
| 72 | Hepatocellular necrosis (HP:0001404) | 2.59151674 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.57600845 |
| 74 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.57066241 |
| 75 | Polyuria (HP:0000103) | 2.54435755 |
| 76 | Status epilepticus (HP:0002133) | 2.50303651 |
| 77 | Gait imbalance (HP:0002141) | 2.49821451 |
| 78 | Scanning speech (HP:0002168) | 2.49580630 |
| 79 | Tubular atrophy (HP:0000092) | 2.49246798 |
| 80 | Slow saccadic eye movements (HP:0000514) | 2.48956178 |
| 81 | Hyperventilation (HP:0002883) | 2.48100002 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.46868315 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.44890134 |
| 84 | Lower limb muscle weakness (HP:0007340) | 2.44164446 |
| 85 | Abnormality of the corticospinal tract (HP:0002492) | 2.44061253 |
| 86 | Peripheral hypomyelination (HP:0007182) | 2.43234114 |
| 87 | Abnormality of magnesium homeostasis (HP:0004921) | 2.42295864 |
| 88 | Methylmalonic acidemia (HP:0002912) | 2.39837837 |
| 89 | Abnormality of macular pigmentation (HP:0008002) | 2.37843407 |
| 90 | Psychosis (HP:0000709) | 2.36877416 |
| 91 | Progressive inability to walk (HP:0002505) | 2.36251260 |
| 92 | Ventricular fibrillation (HP:0001663) | 2.34970702 |
| 93 | Papilledema (HP:0001085) | 2.34699200 |
| 94 | Acute encephalopathy (HP:0006846) | 2.34009289 |
| 95 | Increased circulating renin level (HP:0000848) | 2.33305716 |
| 96 | Polyphagia (HP:0002591) | 2.32713552 |
| 97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.30370315 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 2.27113776 |
| 99 | Methylmalonic aciduria (HP:0012120) | 2.26682409 |
| 100 | Type II lissencephaly (HP:0007260) | 2.22748348 |
| 101 | Late onset (HP:0003584) | 2.21863196 |
| 102 | Muscle stiffness (HP:0003552) | 2.21583662 |
| 103 | Hyperthyroidism (HP:0000836) | 2.19924023 |
| 104 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18916952 |
| 105 | Intention tremor (HP:0002080) | 2.18905707 |
| 106 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18287107 |
| 107 | Cystic liver disease (HP:0006706) | 2.17991025 |
| 108 | Decreased central vision (HP:0007663) | 2.17150009 |
| 109 | Limb dystonia (HP:0002451) | 2.14760058 |
| 110 | Poor eye contact (HP:0000817) | 2.12387633 |
| 111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12312235 |
| 112 | Type I diabetes mellitus (HP:0100651) | 2.12200759 |
| 113 | Renal cortical cysts (HP:0000803) | 2.12030181 |
| 114 | Impaired social interactions (HP:0000735) | 2.11909281 |
| 115 | Abnormal social behavior (HP:0012433) | 2.11909281 |
| 116 | Abnormal pancreas size (HP:0012094) | 2.11717943 |
| 117 | Abnormality of saccadic eye movements (HP:0000570) | 2.10501556 |
| 118 | Fetal akinesia sequence (HP:0001989) | 2.10205351 |
| 119 | Tongue fasciculations (HP:0001308) | 2.09700055 |
| 120 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.09265426 |
| 121 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.09265426 |
| 122 | Clonus (HP:0002169) | 2.09028712 |
| 123 | Furrowed tongue (HP:0000221) | 2.07503346 |
| 124 | Prolonged QT interval (HP:0001657) | 2.07456786 |
| 125 | Hypoventilation (HP:0002791) | 2.06861255 |
| 126 | Abolished electroretinogram (ERG) (HP:0000550) | 2.06199274 |
| 127 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06132052 |
| 128 | Postural tremor (HP:0002174) | 2.05886757 |
| 129 | Bradykinesia (HP:0002067) | 2.05778654 |
| 130 | Tubulointerstitial nephritis (HP:0001970) | 2.02043628 |
| 131 | Impaired smooth pursuit (HP:0007772) | 2.00545862 |
| 132 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.00309580 |
| 133 | Abnormal EKG (HP:0003115) | 2.00195136 |
| 134 | Abnormality of vitamin B metabolism (HP:0004340) | 1.99701806 |
| 135 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99617904 |
| 136 | Intestinal atresia (HP:0011100) | 1.99467085 |
| 137 | Choreoathetosis (HP:0001266) | 1.98759909 |
| 138 | Abnormal urine output (HP:0012590) | 1.98740901 |
| 139 | Chronic hepatic failure (HP:0100626) | 1.97759837 |
| 140 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97286499 |
| 141 | Torticollis (HP:0000473) | 1.94489776 |
| 142 | Male pseudohermaphroditism (HP:0000037) | 1.93126708 |
| 143 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92641278 |
| 144 | Lipid accumulation in hepatocytes (HP:0006561) | 1.92476289 |
| 145 | Specific learning disability (HP:0001328) | 1.92380392 |
| 146 | Epileptiform EEG discharges (HP:0011182) | 1.91409210 |
| 147 | Paraplegia (HP:0010550) | 1.91382266 |
| 148 | Metabolic alkalosis (HP:0200114) | 1.90369360 |
| 149 | Muscular hypotonia of the trunk (HP:0008936) | 1.90364680 |
| 150 | Generalized myoclonic seizures (HP:0002123) | 1.90256505 |
| 151 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89880768 |
| 152 | Cerebral inclusion bodies (HP:0100314) | 1.89611314 |
| 153 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.88588779 |
| 154 | Hypoplasia of the fovea (HP:0007750) | 1.88588779 |
| 155 | Gait ataxia (HP:0002066) | 1.88429391 |
| 156 | Genital tract atresia (HP:0001827) | 1.88241156 |
| 157 | Abnormal albumin level (HP:0012116) | 1.87909710 |
| 158 | Hypoalbuminemia (HP:0003073) | 1.87909710 |
| 159 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87487422 |
| 160 | Absent speech (HP:0001344) | 1.87436381 |
| 161 | Unsteady gait (HP:0002317) | 1.86185151 |
| 162 | Insomnia (HP:0100785) | 1.86102511 |
| 163 | Blue irides (HP:0000635) | 1.84514777 |
| 164 | Increased hepatocellular lipid droplets (HP:0006565) | 1.83246035 |
| 165 | Clumsiness (HP:0002312) | 1.83010379 |
| 166 | Metaphyseal dysplasia (HP:0100255) | 1.81758167 |
| 167 | Poor suck (HP:0002033) | 1.81447759 |
| 168 | Congenital hepatic fibrosis (HP:0002612) | 1.81333354 |
| 169 | Esotropia (HP:0000565) | 1.80958498 |
| 170 | Pendular nystagmus (HP:0012043) | 1.80754497 |
| 171 | Stomatitis (HP:0010280) | 1.80127525 |
| 172 | Septo-optic dysplasia (HP:0100842) | 1.78742714 |
| 173 | Neuronal loss in central nervous system (HP:0002529) | 1.78044589 |
| 174 | Enlarged penis (HP:0000040) | 1.77146048 |
| 175 | Abnormality of renal excretion (HP:0011036) | 1.76626413 |
| 176 | Abnormality of the vocal cords (HP:0008777) | 1.76596636 |
| 177 | Severe muscular hypotonia (HP:0006829) | 1.76270014 |
| 178 | Vaginal atresia (HP:0000148) | 1.75623983 |
| 179 | Optic disc pallor (HP:0000543) | 1.74994957 |
| 180 | Rigidity (HP:0002063) | 1.74677318 |
| 181 | Hypsarrhythmia (HP:0002521) | 1.74213884 |
| 182 | Sclerocornea (HP:0000647) | 1.74086593 |
| 183 | Spastic paraplegia (HP:0001258) | 1.73536401 |
| 184 | Neoplasm of the adrenal gland (HP:0100631) | 1.72421442 |
| 185 | Scotoma (HP:0000575) | 1.72383228 |
| 186 | Anencephaly (HP:0002323) | 1.71127554 |
| 187 | CNS demyelination (HP:0007305) | 1.71087727 |
| 188 | Tachypnea (HP:0002789) | 1.70487093 |
| 189 | Thyroiditis (HP:0100646) | 1.69887842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.77295966 |
| 2 | NTRK3 | 5.09475113 |
| 3 | MAP4K2 | 3.94716870 |
| 4 | MAP3K12 | 3.84432481 |
| 5 | MAP3K4 | 3.36761834 |
| 6 | MARK1 | 3.29026412 |
| 7 | MINK1 | 3.16514483 |
| 8 | MAP2K7 | 2.57941542 |
| 9 | MAP2K4 | 2.46016090 |
| 10 | WNK1 | 2.33913927 |
| 11 | PAK6 | 2.28486920 |
| 12 | PNCK | 2.25786095 |
| 13 | UHMK1 | 2.12098037 |
| 14 | NTRK2 | 2.10538548 |
| 15 | MAP3K9 | 2.08088409 |
| 16 | ADRBK2 | 2.07911653 |
| 17 | TXK | 2.02782886 |
| 18 | ZAK | 2.00524099 |
| 19 | MST4 | 1.97285221 |
| 20 | STK38 | 1.81064755 |
| 21 | BMPR1B | 1.76867331 |
| 22 | CDK19 | 1.67045599 |
| 23 | EIF2AK3 | 1.66772888 |
| 24 | CASK | 1.65099065 |
| 25 | SIK3 | 1.63672865 |
| 26 | EIF2AK1 | 1.50037780 |
| 27 | WNK3 | 1.49151166 |
| 28 | MAPK13 | 1.45832821 |
| 29 | PAK3 | 1.45411378 |
| 30 | CAMK1G | 1.41484446 |
| 31 | TRIM28 | 1.39635694 |
| 32 | PASK | 1.38435089 |
| 33 | LIMK1 | 1.34751583 |
| 34 | STK38L | 1.32874870 |
| 35 | NUAK1 | 1.30268353 |
| 36 | FES | 1.30164590 |
| 37 | PLK2 | 1.28520108 |
| 38 | BCR | 1.28172904 |
| 39 | AKT3 | 1.24433435 |
| 40 | CAMK2A | 1.23147732 |
| 41 | PRKCG | 1.23144247 |
| 42 | NLK | 1.23069387 |
| 43 | OXSR1 | 1.22461360 |
| 44 | NTRK1 | 1.22445564 |
| 45 | LATS2 | 1.21874462 |
| 46 | CDK5 | 1.21361801 |
| 47 | INSRR | 1.19842871 |
| 48 | GRK5 | 1.16129622 |
| 49 | TNK2 | 1.14743022 |
| 50 | CAMKK1 | 1.14708976 |
| 51 | PHKG1 | 1.11261530 |
| 52 | PHKG2 | 1.11261530 |
| 53 | CSNK1G2 | 1.07982161 |
| 54 | GRK7 | 1.05587196 |
| 55 | STK39 | 1.05190897 |
| 56 | MAP2K6 | 1.05189113 |
| 57 | FGFR2 | 1.00591435 |
| 58 | SGK494 | 1.00499247 |
| 59 | SGK223 | 1.00499247 |
| 60 | TNIK | 0.98828225 |
| 61 | LMTK2 | 0.97352724 |
| 62 | STK16 | 0.95882901 |
| 63 | MKNK2 | 0.95725229 |
| 64 | CSNK1G3 | 0.95047900 |
| 65 | NEK1 | 0.94098624 |
| 66 | CAMK1 | 0.91510620 |
| 67 | PRKD3 | 0.89654337 |
| 68 | CDK14 | 0.89530285 |
| 69 | CAMK2G | 0.89308869 |
| 70 | PKN1 | 0.87828986 |
| 71 | PTK2B | 0.87609765 |
| 72 | CDC42BPA | 0.86896334 |
| 73 | CDK18 | 0.86851336 |
| 74 | BRSK2 | 0.84583599 |
| 75 | MUSK | 0.84230589 |
| 76 | CAMK2D | 0.81268231 |
| 77 | CAMK1D | 0.80893943 |
| 78 | ACVR1B | 0.80505581 |
| 79 | CDK15 | 0.80044949 |
| 80 | IRAK2 | 0.79961053 |
| 81 | TEC | 0.79453899 |
| 82 | STK11 | 0.78544470 |
| 83 | PLK3 | 0.78531167 |
| 84 | TSSK6 | 0.77641694 |
| 85 | PINK1 | 0.77030929 |
| 86 | CAMK2B | 0.77024758 |
| 87 | SIK2 | 0.76997275 |
| 88 | WNK4 | 0.76272573 |
| 89 | ROCK2 | 0.75619881 |
| 90 | PRKCH | 0.75385183 |
| 91 | CSNK1A1L | 0.72582549 |
| 92 | PRKCE | 0.72229887 |
| 93 | TAOK3 | 0.70631115 |
| 94 | CAMKK2 | 0.70425809 |
| 95 | STK3 | 0.70354700 |
| 96 | KSR1 | 0.68909366 |
| 97 | PDK2 | 0.68117174 |
| 98 | NEK6 | 0.67931025 |
| 99 | CDK11A | 0.66214810 |
| 100 | MAP3K11 | 0.65599267 |
| 101 | EPHA4 | 0.65597379 |
| 102 | SGK1 | 0.65497443 |
| 103 | MKNK1 | 0.65466171 |
| 104 | DYRK2 | 0.64607013 |
| 105 | PRKCZ | 0.64067085 |
| 106 | SGK2 | 0.61857364 |
| 107 | DAPK2 | 0.60740031 |
| 108 | TYRO3 | 0.60204486 |
| 109 | PRKAA2 | 0.59576473 |
| 110 | DAPK1 | 0.59511885 |
| 111 | MARK2 | 0.58787456 |
| 112 | BCKDK | 0.58525307 |
| 113 | MAPK10 | 0.56949946 |
| 114 | CSNK1G1 | 0.56560820 |
| 115 | DYRK1A | 0.54226329 |
| 116 | TAOK1 | 0.53781465 |
| 117 | RPS6KA3 | 0.53734962 |
| 118 | IRAK1 | 0.52772640 |
| 119 | IKBKB | 0.52332191 |
| 120 | PRKG1 | 0.52188384 |
| 121 | CSNK1E | 0.51063640 |
| 122 | TRPM7 | 0.50731960 |
| 123 | PRKCI | 0.49734642 |
| 124 | ROCK1 | 0.49572888 |
| 125 | CSNK1A1 | 0.48854429 |
| 126 | TIE1 | 0.47869270 |
| 127 | ERBB3 | 0.47735193 |
| 128 | TLK1 | 0.47419403 |
| 129 | PRKCQ | 0.47396086 |
| 130 | GRK1 | 0.44982765 |
| 131 | ADRBK1 | 0.43992146 |
| 132 | PRKCB | 0.43929110 |
| 133 | CSNK1D | 0.43729435 |
| 134 | PRKACA | 0.43087329 |
| 135 | MAP3K1 | 0.42878411 |
| 136 | VRK1 | 0.42837090 |
| 137 | RPS6KA5 | 0.42446754 |
| 138 | CDK3 | 0.42304678 |
| 139 | PRKAA1 | 0.42266388 |
| 140 | PRKD2 | 0.41613808 |
| 141 | FER | 0.40910193 |
| 142 | * PRKCA | 0.40461221 |
| 143 | MAP3K2 | 0.39951714 |
| 144 | SGK3 | 0.39387747 |
| 145 | MAPKAPK5 | 0.37469520 |
| 146 | PRKACB | 0.33717096 |
| 147 | ITK | 0.32614176 |
| 148 | ATM | 0.32342662 |
| 149 | MAP2K1 | 0.28997353 |
| 150 | HIPK2 | 0.27060592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.81303915 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.05257748 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.78697244 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.29267820 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 3.13269225 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.53691448 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53362411 |
| 8 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.38234491 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.33344801 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.32276802 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.26368117 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.20849596 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18400830 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.12886372 |
| 15 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.10355137 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.08069876 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.02118291 |
| 18 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.02060965 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.95744424 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.90851578 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.89113015 |
| 22 | Proteasome_Homo sapiens_hsa03050 | 1.87558918 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.87504292 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.87357787 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.85878382 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.75287439 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74910956 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.74009970 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.72111995 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71718613 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70930295 |
| 32 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.68043939 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.66500122 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66002397 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.59287761 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58195951 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.57222435 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.56678777 |
| 39 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47583719 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.46805289 |
| 41 | Circadian rhythm_Homo sapiens_hsa04710 | 1.39498063 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37911298 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.35043658 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33992671 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31959444 |
| 46 | RNA polymerase_Homo sapiens_hsa03020 | 1.30547697 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.30259140 |
| 48 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27473762 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26318485 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.25018316 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.24169205 |
| 52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21093731 |
| 53 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18695766 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.18519988 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17579082 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17055505 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.15286097 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 1.14256886 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14059793 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10058519 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 1.09585794 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09410725 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.09346888 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04594179 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02328782 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99744906 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.99503023 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96374713 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96175275 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95513988 |
| 71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95225858 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.95186227 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.91491405 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90442728 |
| 75 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89241559 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89181979 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88631695 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.87157998 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84743801 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84637206 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81640196 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.80670063 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80587026 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80484806 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79940813 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76492798 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73382325 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71096388 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70224722 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69919570 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69864132 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69171207 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68915431 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67588983 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67530599 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66111802 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63121472 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62945715 |
| 99 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62520042 |
| 100 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61927566 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61648691 |
| 102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60197521 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59709010 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59644670 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59398367 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59100931 |
| 107 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.58803392 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58366518 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57765517 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57540048 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57507209 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57179219 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56900554 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55953630 |
| 115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55644056 |
| 116 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.54810534 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53697992 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.53628863 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52997563 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52474122 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51586360 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51548935 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51309098 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.50942450 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49305747 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48800736 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47728510 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.45370244 |
| 129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44921876 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.44328918 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43803538 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42603469 |
| 133 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42124267 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41000500 |
| 135 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40703146 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.40506596 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38504064 |
| 138 | Alcoholism_Homo sapiens_hsa05034 | 0.38316153 |
| 139 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.37607404 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36831694 |
| 141 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35451078 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35167480 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34775675 |
| 144 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34451402 |
| 145 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33974995 |
| 146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.32672860 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32586124 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32141578 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31751918 |
| 150 | Endocytosis_Homo sapiens_hsa04144 | 0.26793254 |
| 151 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25901946 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25894657 |
| 153 | Phagosome_Homo sapiens_hsa04145 | 0.25078677 |

